Lv7
4985 积分 2021-08-08 加入
Different Contributions of Dyslipidemia and Obesity to the Natural History of Type 2 Diabetes: 3-Year Cohort Study in China
5小时前
已完结
Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China
5小时前
已完结
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease
23天前
已完结
Type 2 diabetes（和2017年的不一样）
1个月前
已完结
Type 2 diabetes
1个月前
已完结
Association of Sleep Duration and Overweight/Obesity among Children in China
1个月前
已完结
GIP and GLP-1, the two incretin hormones: Similarities and differences
1个月前
已完结
Circulation and Degradation of GIP and GLP-1
1个月前
已完结
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes
1个月前
已完结
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
1个月前
已完结
皖公网安备34019202002308
